Triphasic oral contraceptive treatment alters the behavior and neurobiology of female cynomolgus monkeys

Psychoneuroendocrinology

Volumn 29, Issue 1, 2004, Pages 21-34

  Henderson, J A ^a   Shively, C A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; Cortisol; Heart rate; Oral contraceptive; Primate; Serotonin

Indexed keywords

CORTICOTROPIN; FENFLURAMINE; HYDROCORTISONE; PROLACTIN; SEROTONIN AGONIST; TRIPHASIC CONTRACEPTIVE AGENT;

AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MONKEY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR;

EID: 0142122331     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(02)00132-4     Document Type: Article

References (51)

1. Adams M.R., Williams J.K., Clarkson T.B., Jayo M.L. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys. Baillieres Clin. Obstet. Gynaecol. 5:1991;915-934.
2. Algeri S., Ponzio F., Dolfini E., Jori A. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat. Neuroendocrinology. 22:1976;343-351.
3. Altmann J. Observational study of behavior: sampling methods. Behaviour. 48:1974;1-41.
4. Asnis G.M., Sachar E.J., Langer G., Tabrizi M.A., Nathan R.S., Halpern F.S., Halbreich U. Prolactin responses to haloperidol in normal young women. Psychoneuroendocrinology. 13:1988;515-520.
5. Bernasconi S., Garattini S., Samanin R. The effect of steroid contraceptives on the concentrations of brain monoamines in rats and mice. Arch. Int. Pharmacology. 222:1976;272-281.
6. Bethea C.L., Mirkes S.J., Shively C.A., Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol. Psychiatry. 47:2000;562-576.
7. Brown I.S., Forand A.Q., Payne R.B. Hormonal influences on psychomotor reminiscence. Percept. Mot. Skills. 58:1984;383-389.
8. Carr B.R., Griffin J.E. Fertility control and its complications. Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. Williams Textbook of Endocrinology. 9th ed:1998;901-926 W.B. Saunders, Philadelphia.
9. Clarkson T.B., Shively C.A., Morgan T.M., Koritnik D.R., Adams M.R., Kaplan J.R. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet. Gynecol. 75:1990;217-222.
10. Farmer R.D., Lawrenson R.A., Thompson C.R., Kennedy J.G., Hambleton I.R. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet. 349:1997;83-88.
11. Frost P. Preference for darker faces in photographs at different phases of the menstrual cycle: preliminary assessment of evidence for a hormonal relationship. Percept. Mot. Skills. 79:1994;507-514.
12. Garrett K.F., Elder S.T. The menstrual cycle from a bio-behavioral approach: A comparison of oral contraceptive and non-contraceptive users. Intern. J. Psychophysiol. 1:1984;209-214.
13. Goldzieher J.W., Fotherby K. Pharmacology of the Contraceptive Steroids. 1994;Raven Press, New York.
14. Hannaford P.C., Kay C.R. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study. Br. J. Gen. Pract. 48:1998;1657-1662.
15. Hapidou E.G., Rollman G.B. Menstrual cycle modulation of tender points. Pain. 77:1998;151-161.
16. Henzl M.R. Contraceptive hormones and their clinical use. Yen S.S.C., Jaffe R.B. Reproductive Endocrinology. Physiology, Pathophysiology and Clinical Management. 1991;807-829 WB Saunders Company, Philadelphia.
17. Herzberg B.N., Draper K.C., Johnson A.L., Nicol G.C. Oral contraceptives, depression, and libido. Br. Med. J. 3:1971;495-500.
18. Kalin N.H., Carnes M. Biological correlates of attachment bond disruption in humand and nonhuman primates. Prog. Neuropsycho-pharmacol. Biol. Psychiatry. 8:1984;459-469.
19. Kaplan J.R., Adams M.R., Koritnik D.R., Rose J.C., Manuck S.B. Adrenal responsiveness and social status in intact and ovariectomized Macaca fascicularis. Am. J. Primatol. 11:1986;181-193.
20. Kaplan J.R., Adams M.R., Anthony M.S., Morgan T.M., Manuck S.B., Clarkson T.B. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler. Thromb. Vasc. Biol. 15:1995;2094-2100.
21. Kattapong K.R., Fogg L.F., Eastman C.I. Effect of sex, menstrual cycle phase, and oral contraceptive use on circadian temperature rhythms. Chronobiol. Int. 12:1995;257-266.
22. Kirschbaum C., Pirke K.-M., Hellhammer D.H. Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication. Psychoneoroendocrinology. 20:1995;509-514.
23. Kirschbaum C., Platte P., Pirke K.-M., Hellhammer D.H. Adrenocortical activation following stressful exercise: further evidence for attenuated free cortisol responses in women using oral contraceptives. Stress Medicine. 12:1996;137-143.
24. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 61:1998;154-162.
25. Lesch K., Merschdorf U. Impulsivity, aggression and serotonin: a molecular psychobiological perspective. Behavioral Sciences and the Law. 18:2000;581-604.
26. Marinari K.T., Leshner A.I., Doyle M.P. Menstrual cycle status and adrenocortical reactivity to psychological stress. Psychoneuroendocrinology. 1:1976;213-218.
27. Mestman J.H., Anderson G.V., Nelson D.H. Adrenal-pituitary responsiveness during therapy with an oral contraceptive. Obstet. Gynecol. 31:1968;386-387.
28. Moller S.E. Tryptophan and tyrosine availability and oral contraceptives. Lancet. 2:1979;472.
29. Moller S.E. Effect of oral contraceptives on tryptophan and tyrosine availability: Evidence for a possible contribution to mental depression. Neuropsychology. 7:1981;192-200.
30. Petiot J.C., Parrot J.E. Effects of the ovarian and contraceptive cycles on absolute thresholds, auditory fatigue and recovery from temporary threshold shifts at 4 and 6 kHz. Audiology. 23:1984;581-598.
31. Petitti D.B., Sidney S., Bernstein A., Wolf S., Quesenberry C., Ziel H.K. Stroke in users of low-dose oral contraceptives. New Engl. J. Med. 335:1996;8-15.
32. Register T.C., Jayo M.J., Jerome C.P. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporosis Int. 7:1997;348-353.
33. Rose D.P., Toseland P.A. Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration. Metabolism. 22:1973;165-171.
34. Sanders S.A., Graham C.A., Bass J.L., Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 64:2001;51-58.
35. Scanlan J.M., Werner J.J., Legg R.L., Laudenslager M.L. Natural killer cell activity is reduced in association with oral contraceptive use. Psychoneuroendocrinology. 20:1995;281-287.
36. Schlesselman J.J. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Human Repro. 12:1997;1851-1863.
37. Seralini G.E. Regulation factors of corticosteroid-binding globulin: lessons from ontogenesis. Horm. Res. 45:1996;192-196.
38. Shapiro S., Rosenberg L., Hoffman M., Truter H., Cooper D., Rao S., Dent D., Gudgeon A., van Zyl J., Katzenellenbogen J., Baillie R. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am. J. Epidemiol. 151:2000;396-403.
39. Shively C.A., Kaplan J.R., Adams M.R. Effects of ovariectomy, social instability and social status on female Macaca fascicularis social behavior. Physiol. Behav. 36:1986;1147-1153.
40. Shively C.A., Manuck S.B., Kaplan J.R., Koritnik D.R. Oral contraceptive administration, interfemale relationships, and sexual behavior in Macaca fascicularis. Arch. Sex. Behav. 19:1990;101-117.
41. Shively C.A., Kaplan J.R. Stability of social status rankings of female cynomolgus monkeys, of varying reproductive condition, in different social groups. Am. J. Primatol. 23:1991;239-245.
42. Shively C.A., Clarkson T.B. Social status and coronary artery atherosclerosis in female monkeys. Arterioscler. Thromb. 14:1994;721-726.
43. Shively C.A., Fontenot M.B., Kaplan J.R. Social status, behavior, and central serotonergic responsivity in female cynomolgus monkeys. Am. J. Primatol. 37:1995;333-339.
44. Shively C.A. Social subordination stress, behavior, and central monoaminergic function in female cynomolgus monkeys. Biol. Psychiat. 44:1998;882-891.
45. Shively C.A. Behavioral and neurobiological effects of estrogen replacement therapy and a history of triphasic oral contraceptive exposure. Psychoneuroendocrinology. 23:1998;713-732.
46. Slap G.B. Oral contraceptives and depression. Impact, prevalence and cause. J. Adolesc. Health. 2:1981;53-64.
47. Slone D., Shapiro S., Kaufman D.W., Rosenberg L., Miettinen O.S., Stolley P.D. Risk of myocardial infarction in relation to current and discontinued use of contraceptive agents. New Engl. J. Med. 305:1981;420-424.
48. Stratakis C.A., Chrousos G.P. Neuroendocrinology and pathophysiology of the stress system. Ann. NY Acad. Sci. 771:1995;1-18.
49. Toseland P.A., Price S. Tryptophan and oral contraceptives. Br Med J. 1:(646):1969;777.
50. De Waal F.B.M., van Ren R. Comparison of the reconciliation behavior of stumptail and rhesus macaques. Ethology. 78:1988;129-142.
51. Wuttke W., Arnold P., Becker D., Creutzfeldt O., Langenstein S., Tirsch W. Circulating hormones, EEG, and performance in psychological tests of women with and without oral contraceptives. Psychoneuroendocrinology. 1:1975;141-151.